Hydrochlorothiazide Tablet
Product Images NDC 0172-2083

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 0172-2083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of hydrochlorothiazide, depicting its benzothiadiazine ring system with chlorine, sulfonamide, and other functional groups as detailed in the image.*

FDA Label Image

Image 2

Hydrochlorothiazide Tablets USP 25 mg oral tablets in a 100-tablet package, labeled by Teva Pharmaceuticals USA, Inc. The label includes the NDC number 0172-2083-60 and states Rx only. The packaging also features a barcode and serialization coding area.*

FDA Label Image

Image 3

Label for Hydrochlorothiazide Tablets USP 50 mg oral tablets by Teva Pharmaceuticals USA, Inc. The label shows a package size of 100 tablets, with NDC 0172-2089-60, a red box highlighting strength 50 mg, and storage instructions. The Teva logo is on the bottom right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.